Synbio International Inc. secures rights to conduct clinical trials for AI-powered depression screening technology (NIMS: Non ...

A real-world analysis suggests antidepressants may lead to faster cognitive decline in patients with dementia, but experts ...

The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.

Synbio International Inc. secures rights to conduct clinical trials for AI-powered depression screening technology (NIMS: Non-invasive Mental Screening).NIMS is a fast, highly accurate and cost-effect ...

In the UK, around 10% of the general population experiences insomnia symptoms, which contributes to their poor mental health, ...

Integrating routine psychological health screening and treatment during and after pregnancy may reduce the risk of adverse pregnancy outcomes and improve maternal cardiovascular health, according to a ...

Q4 2024 Earnings Conference Call February 25, 2025 8:00 AM ETCompany ParticipantsBriana Gotlin - Vice President, ...

Fourth quarter 2024 net sales of GOCOVRI ® increased 15% to $36.9 million, compared to the same period in 2023. Full year net sales of GOCOVRI increased 9% to $130.8 million, compared to full year ...

Long COVID is a complex and often debilitating complication following COVID-19 infection. It affects millions worldwide, presenting with symptoms such as persistent fatigue, cognitive impairment ...

Thirty years ago, medical and psychological experts believed attention deficit hyperactivity disorder (ADHD) was a childhood ...

One in 20 U.S. adults experience seasonal depression, most often in winter. UVA professor Kim Penberthy shares self-care tips ...

Vitamin D deficiency (VDD) is independently associated with increased depression risk in patients with chronic kidney disease ...